Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Biochemical Pharmacology|September 10, 2008
Apoptosis induction by Bcl-2 proteins independent of the BH3 domainAmir M Hossini, Jürgen EberleCurrent Genomics|June 10, 2009
Expression and function of bcl-2 proteins in melanomaJürgen Eberle, Amir M HossiniAdvances in Experimental Medicine and Biology|January 13, 2022
Skin Mirrors Brain: A Chance for Alzheimer's Disease ResearchChristos C Zouboulis, Evgenia Makrantonaki, Amir M HossiniDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 7, 2007
Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approachesJürgen Eberle, Bahtier M Kurbanov, Amir M Hossini, et al.Experimental Dermatology|December 22, 2007
Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanomaJürgen Eberle, Lothar F Fecker, Amir M Hossini, et al.Dermatology (Basel, Switzerland)|June 2, 2021
3D-SeboSkin Model for Human ex vivo Studies of Hidradenitis Suppurativa/Acne InversaXiaoxiao Hou, Amir M Hossini, Georgios Nikolakis, et al.Plos One|April 17, 2012
Mutual regulation of Bcl-2 proteins independent of the BH3 domain as shown by the BH3-lacking protein Bcl-x(AK)Michael Plötz, Amir M Hossini, Bernhard Gillissen, et al.Experimental Dermatology|April 2, 2015
Ex vivo human skin and SZ95 sebocytes exhibit a homoeostatic interaction in a novel coculture contact modelGeorgios Nikolakis, Holger Seltmann, Amir M Hossini, et al.FEBS Letters|October 24, 2003
Conditional expression of exogenous Bcl-X(S) triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenograftsAmir M Hossini, Jürgen Eberle, Lothar F Fecker, et al.Pharmaceutics|February 25, 2023
HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne InversaChristos C Zouboulis, Xiaoxiao Hou, Henriette von Waldthausen, et al.Pageof 3